LEVERONE JASON A. (Chief Financial Officer) sold 2.3% of their position (303.00 shares) of ONKURE THERAPEUTICS, INC. on the open market
Open‑market sale worth $794.92 — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/24/2025ACC: 0001692747-25-000003
Officer· Chief Financial Officer
Since Oct 2024
-303.00
Net shares
Net seller
$794.92
Total sold
1
Open market trades
0B · 1S
1
Total transactions
303.00 disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−303.00
Price / share
$2.62
Trade value
$794.92
% of position
2.3%
9/22/2025
12.91K→12.60K
Total
Net shares
−303.00
Net value
-$794.92
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 9/22/2025 | S · Sale | −303.00 | $2.62 | $794.92 | 2.3% | 12.91K | 12.60K |
| Total | −303.00 | -$794.92 | ||||||
Derivative Transactions0
No derivative transactions reported